ARCHETYPE Level of certainty (Brighton Collaboration) (openEHR-EHR-CLUSTER.level_of_certainty_bc.v0)

Name: Level of certainty (Brighton Collaboration)
License: http://creativecommons.org/licenses/by-sa/4.0/

ARCHETYPE ID	openEHR-EHR-CLUSTER.level_of_certainty_bc.v0
Concept	Level of certainty (Brighton Collaboration)
Description	Determination of the level of certainty for a diagnosis made following a vaccine-related adverse event, based on standardised criteria established by the Brighton Collaboration.
Use	Use to record the level of diagnostic certainty according to the Brighton Collaboration criteria.
Purpose	To record the level of diagnostic certainty according to the Brighton Collaboration criteria.
References	Guillain Barré and Miller Fisher Syndromes: Case Definition Companion Guide v1.0. Brighton Collaboration, USA; 05 Mar 2021. Available from: https://brightoncollaboration.us/guillain-barre-and-miller-fisher-syndromes-case-definition-companion-guide/. Accessed 2023 Jun 16. Kohl KS, Bonhoeffer J, Braun MM, et al.; The Brighton Collaboration. The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization. In: Henriksen K, Battles JB, Marks ES, et al., editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb. Available from: https://www.ncbi.nlm.nih.gov/books/NBK20507/. Available from: https://www.ncbi.nlm.nih.gov/books/NBK20507/. Accessed 2023 Jun 16.
Copyright	© openEHR Foundation
Authors	Author name: Heather Leslie Organisation: Atomica Informatics Email: heather.leslie@atomicainformatics.com Date originally authored: 2023-06-16
Other Details Language	Author name: Heather Leslie Organisation: Atomica Informatics Email: heather.leslie@atomicainformatics.com Date originally authored: 2023-06-16
Other Details (Language Independent)	Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/. Custodian Organisation: openEHR Foundation References: Guillain Barré and Miller Fisher Syndromes: Case Definition Companion Guide v1.0. Brighton Collaboration, USA; 05 Mar 2021. Available from: https://brightoncollaboration.us/guillain-barre-and-miller-fisher-syndromes-case-definition-companion-guide/. Accessed 2023 Jun 16. Kohl KS, Bonhoeffer J, Braun MM, et al.; The Brighton Collaboration. The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization. In: Henriksen K, Battles JB, Marks ES, et al., editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb. Available from: https://www.ncbi.nlm.nih.gov/books/NBK20507/. Available from: https://www.ncbi.nlm.nih.gov/books/NBK20507/. Accessed 2023 Jun 16. Original Namespace: org.openehr Original Publisher: openEHR Foundation Custodian Namespace: org.openehr MD5-CAM-1.0.1: AE7DF7ADC0FFD6D4AC9FFD14CB0A47B6 Build Uid: 60ad62e1-11e8-449f-8d5d-42c6b14122bb Revision: 0.0.1-alpha
Keywords
Lifecycle	in_development
UID	9072bf18-7cb7-4c5a-97ba-b3d137b69ceb
Language used	en
Citeable Identifier	1013.1.6952
Revision Number	0.0.1-alpha
items
Index disease
Level of certainty	Level of certainty: at0003::Level 1 [Highest level of specificity; least sensitive.] at0004::Level 2 [Intermediate level of specificity; lower sensitivity.] at0005::Level 3 [Lower level of specificity; highly sensitive.] at0006::Level 4 [Insufficient information available to meet any level of case definition.] at0007::Level 5 [Not a case.]
Other contributors
Translators